HYPOTONIA NEONATAL

This adverse event was reported 1563 times

These drugs are most commonly taken by patients reporting HYPOTONIA NEONATAL:

# Drug Count
0 VENLAFAXINE HYDROCHLORIDE 209
1 QUETIAPINE 175
2 VENLAFAXINE 167
3 LAMOTRIGINE 112
4 OLANZAPINE 99
5 LAMOTIRIGINE 93
6 LAMOTRIGINE CHEWABLE DISPERSIBLE 93
7 LAMOTRIGINE EXTENDED-RELEASE 93
8 LEVETIRACETAM 84
9 FOLIC ACID 76
See all common drugs associated with HYPOTONIA NEONATAL

HYPOTONIA NEONATAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DISULFIRAM 10 0.0088
1 METHYLDOPA 31 0.0063
2 ATRACURIUM BESYLATE 3 0.0042
3 BETAXOLOL 3 0.0037
4 CLOMIPRAMINE HYDROCHLORIDE 16 0.0035
5 DARIDOREXANT 9 0.0032
6 CEFIXIME 9 0.0029
7 ZIDOVUDINE 30 0.0029
8 ZIPRASIDONE 10 0.0028
9 NELFINAVIR MESYLATE 5 0.0024
See all drugs enriched for association with HYPOTONIA NEONATAL

HYPOTONIA NEONATAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Aldehyde Dehydrogenase Inhibitor [EPC] 10 0.0088
1 Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] 4 0.0022
2 Carbamoyl Phosphate Synthetase 1 Activator [EPC] 1 0.0013
3 Vitamin K [EPC] 11 0.0013
4 Prostaglandin E1 Analog [EPC] 21 0.0013
5 Prostacycline [EPC] 1 0.0011
6 Oxytocic [EPC] 3 0.0010
7 Progesterone [EPC] 22 0.0009
8 Cannabinoid [EPC] 7 0.0009
9 Surfactant [EPC] 1 0.0009
See all drug classes enriched for association with HYPOTONIA NEONATAL